{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:31:55Z","timestamp":1791210715020,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T00:00:00Z","timestamp":1417046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1038\/gt.2014.104","type":"journal-article","created":{"date-parts":[[2014,11,27]],"date-time":"2014-11-27T11:16:57Z","timestamp":1417087017000},"page":"209-215","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["The Tol2 transposon system mediates the genetic engineering of T-cells with CD19-specific chimeric antigen receptors for B-cell malignancies"],"prefix":"10.1038","volume":"22","author":[{"given":"T","family":"Tsukahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Iwase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ohmine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Uchibori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Saga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Urabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Mizukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Brentjens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,27]]},"reference":[{"key":"BFgt2014104_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.4161\/onci.22524","volume":"1","author":"ML Davila","year":"2012","unstructured":"Davila ML, Brentjens R, Wang X, Riviere I, Sadelain M . How do CARs work?: Early insights from recent clinical studies targeting CD19. Oncoimmunology 2012; 1: 1577\u20131583.","journal-title":"Oncoimmunology"},{"key":"BFgt2014104_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/nrclinonc.2013.46","volume":"10","author":"JN Kochenderfer","year":"2013","unstructured":"Kochenderfer JN, Rosenberg SA . Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors. Nat Rev Clin Oncol 2013; 10: 267\u2013276.","journal-title":"Nat Rev Clin Oncol"},{"issue":"Suppl 1","key":"BFgt2014104_CR3","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1186\/gb-2007-8-s1-s7","volume":"8","author":"K Kawakami","year":"2007","unstructured":"Kawakami K . Tol2: a versatile gene transfer vector in vertebrates. Genome Biol 2007; 8 (Suppl 1): S7.","journal-title":"Genome Biol"},{"key":"BFgt2014104_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1472-6750-10-3","volume":"10","author":"K Yagita","year":"2010","unstructured":"Yagita K, Yamanaka I, Emoto N, Kawakami K, Shimada S . Real-time monitoring of circadian clock oscillations in primary cultures of mammalian cells using Tol2 transposon-mediated gene transfer strategy. BMC Biotechnol 2010; 10: 3.","journal-title":"BMC Biotechnol"},{"key":"BFgt2014104_CR5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1534\/genetics.166.2.895","volume":"166","author":"K Kawakami","year":"2004","unstructured":"Kawakami K, Noda T . Transposition of the Tol2 element, an Ac-like element from the Japanese medaka fish Oryzias latipes, in mouse embryonic stem cells. Genetics 2004; 166: 895\u2013899.","journal-title":"Genetics"},{"key":"BFgt2014104_CR6","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1186\/1471-2164-10-477","volume":"10","author":"ML Suster","year":"2009","unstructured":"Suster ML, Sumiyama K, Kawakami K . Transposon-mediated BAC transgenesis in zebrafish and mice. BMC Genomics 2009; 10: 477.","journal-title":"BMC Genomics"},{"key":"BFgt2014104_CR7","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1534\/genetics.106.060244","volume":"174","author":"A Urasaki","year":"2006","unstructured":"Urasaki A, Morvan G, Kawakami K . Functional dissection of the Tol2 transposable element identified the minimal cis-sequence and a highly repetitive sequence in the subterminal region essential for transposition. Genetics 2006; 174: 639\u2013649.","journal-title":"Genetics"},{"key":"BFgt2014104_CR8","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1093\/nar\/gks643","volume":"40","author":"M Rostovskaya","year":"2012","unstructured":"Rostovskaya M, Fu J, Obst M, Baer I, Weidlich S, Wang H et al. Transposon-mediated BAC transgenesis in human ES cells. Nucleic Acids Res 2012; 40: e150.","journal-title":"Nucleic Acids Res"},{"key":"BFgt2014104_CR9","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1038\/mt.2010.47","volume":"18","author":"I Grabundzija","year":"2010","unstructured":"Grabundzija I, Irgang M, Mates L, Belay E, Matrai J, Gogol-Doring A et al. Comparative analysis of transposable element vector systems in human cells. Mol Ther 2010; 18: 1200\u20131209.","journal-title":"Mol Ther"},{"key":"BFgt2014104_CR10","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1089\/hum.2009.114","volume":"21","author":"PV Manuri","year":"2010","unstructured":"Manuri PV, Wilson MH, Maiti SN, Mi T, Singh H, Olivares S et al. piggyBac transposon\/transposase system to generate CD19-specific T cells for the treatment of B-lineage malignancies. Hum Gene Ther 2010; 21: 427\u2013437.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014104_CR11","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1158\/0008-5472.CAN-07-5600","volume":"68","author":"H Singh","year":"2008","unstructured":"Singh H, Manuri PR, Olivares S, Dara N, Dawson MJ, Huls H et al. Redirecting specificity of T-cell populations for CD19 using the Sleeping Beauty system. Cancer Res 2008; 68: 2961\u20132971.","journal-title":"Cancer Res"},{"key":"BFgt2014104_CR12","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1089\/hum.2011.167","volume":"23","author":"P Kebriaei","year":"2012","unstructured":"Kebriaei P, Huls H, Jena B, Munsell M, Jackson R, Lee DA et al. Infusing CD19-directed T cells to augment disease control in patients undergoing autologous hematopoietic stem-cell transplantation for advanced B-lymphoid malignancies. Hum Gene Ther 2012; 23: 444\u2013450.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014104_CR13","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1158\/0008-5472.CAN-10-3843","volume":"71","author":"H Singh","year":"2011","unstructured":"Singh H, Figliola MJ, Dawson MJ, Huls H, Olivares S, Switzer K et al. Reprogramming CD19-specific T cells with IL-21 signaling can improve adoptive immunotherapy of B-lineage malignancies. Cancer Res 2011; 71: 3516\u20133527.","journal-title":"Cancer Res"},{"key":"BFgt2014104_CR14","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jcyt.2014.05.022","volume":"16","author":"S Saito","year":"2014","unstructured":"Saito S, Nakazawa Y, Sueki A, Matsuda K, Tanaka M, Yanagisawa R et al. Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia. Cytotherapy 2014; 16: 1257\u20131269.","journal-title":"Cytotherapy"},{"key":"BFgt2014104_CR15","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbrc.2013.07.030","volume":"438","author":"T Tsukahara","year":"2013","unstructured":"Tsukahara T, Ohmine K, Yamamoto C, Uchibori R, Ido H, Teruya T et al. CD19 target-engineered T-cells accumulate at tumor lesions in human B-cell lymphoma xenograft mouse models. Biochem Biophys Res Commun 2013; 438: 84\u201389.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt2014104_CR16","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1038\/ni.2762","volume":"14","author":"T Okazaki","year":"2013","unstructured":"Okazaki T, Chikuma S, Iwai Y, Fagarasan S, Honjo T . A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application. Nat Immunol 2013; 14: 1212\u20131218.","journal-title":"Nat Immunol"},{"key":"BFgt2014104_CR17","doi-asserted-by":"publisher","first-page":"5636","DOI":"10.1158\/1078-0432.CCR-13-0458","volume":"19","author":"LB John","year":"2013","unstructured":"John LB, Devaud C, Duong CP, Yong CS, Beavis PA, Haynes NM et al. Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells. Clin Cancer Res 2013; 19: 5636\u20135646.","journal-title":"Clin Cancer Res"},{"key":"BFgt2014104_CR18","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.smim.2012.02.005","volume":"24","author":"W Lundstrom","year":"2012","unstructured":"Lundstrom W, Fewkes NM, Mackall CL . IL-7 in human health and disease. Semin Immunol 2012; 24: 218\u2013224.","journal-title":"Semin Immunol"},{"key":"BFgt2014104_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1089\/104303401750214276","volume":"12","author":"KQ Xin","year":"2001","unstructured":"Xin KQ, Urabe M, Yang J, Nomiyama K, Mizukami H, Hamajima K et al. A novel recombinant adeno-associated virus vaccine induces a long-term humoral immune response to human immunodeficiency virus. Hum Gene Ther 2001; 12: 1047\u20131061.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014104_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/CJI.0b013e3182811ce9","volume":"36","author":"SN Maiti","year":"2013","unstructured":"Maiti SN, Huls H, Singh H, Dawson M, Figliola M, Olivares S et al. Sleeping beauty system to redirect T-cell specificity for human applications. J Immunother 2013; 36: 112\u2013123.","journal-title":"J Immunother"},{"key":"BFgt2014104_CR21","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/gt.2009.54","volume":"16","author":"PD Peng","year":"2009","unstructured":"Peng PD, Cohen CJ, Yang S, Hsu C, Jones S, Zhao Y et al. Efficient nonviral Sleeping Beauty transposon-based TCR gene transfer to peripheral blood lymphocytes confers antigen-specific antitumor reactivity. Gene Therapy 2009; 16: 1042\u20131049.","journal-title":"Gene Therapy"},{"key":"BFgt2014104_CR22","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/gt.2011.40","volume":"18","author":"Z Jin","year":"2011","unstructured":"Jin Z, Maiti S, Huls H, Singh H, Olivares S, Mates L et al. The hyperactive Sleeping Beauty transposase SB100X improves the genetic modification of T cells to express a chimeric antigen receptor. Gene Therapy 2011; 18: 849\u2013856.","journal-title":"Gene Therapy"},{"key":"BFgt2014104_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1126\/science.1088547","volume":"302","author":"S Hacein-Bey-Abina","year":"2003","unstructured":"Hacein-Bey-Abina S, Von Kalle C, Schmidt M, McCormack MP, Wulffraat N, Leboulch P et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003; 302: 415\u2013419.","journal-title":"Science"},{"key":"BFgt2014104_CR24","doi-asserted-by":"publisher","first-page":"132ra53","DOI":"10.1126\/scitranslmed.3003761","volume":"4","author":"J Scholler","year":"2012","unstructured":"Scholler J, Brady TL, Binder-Scholl G, Hwang WT, Plesa G, Hege KM et al. Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. Sci Transl Med 2012; 4: 132ra53.","journal-title":"Sci Transl Med"},{"key":"BFgt2014104_CR25","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1038\/mt.2010.141","volume":"18","author":"X Huang","year":"2010","unstructured":"Huang X, Guo H, Tammana S, Jung YC, Mellgren E, Bassi P et al. Gene transfer efficiency and genome-wide integration profiling of Sleeping Beauty, Tol2, and piggyBac transposons in human primary T cells. Mol Ther 2010; 18: 1803\u20131813.","journal-title":"Mol Ther"},{"key":"BFgt2014104_CR26","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/BF02994009","volume":"73","author":"K Kogure","year":"2001","unstructured":"Kogure K, Urabe M, Mizukami H, Kume A, Sato Y, Monahan J et al. Targeted integration of foreign DNA into a defined locus on chromosome 19 in K562 cells using AAV-derived components. Int J Hematol 2001; 73: 469\u2013475.","journal-title":"Int J Hematol"},{"key":"BFgt2014104_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nrc3179","volume":"12","author":"M Sadelain","year":"2012","unstructured":"Sadelain M, Papapetrou EP, Bushman FD . Safe harbours for the integration of new DNA in the human genome. Nat Rev Cancer 2012; 12: 51\u201358.","journal-title":"Nat Rev Cancer"},{"key":"BFgt2014104_CR28","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.1093\/nar\/gks317","volume":"40","author":"I Ammar","year":"2012","unstructured":"Ammar I, Gogol-Doring A, Miskey C, Chen W, Cathomen T, Izsvak Z et al. Retargeting transposon insertions by the adeno-associated virus Rep protein. Nucleic Acids Res 2012; 40: 6693\u20136712.","journal-title":"Nucleic Acids Res"},{"issue":"Pt 1","key":"BFgt2014104_CR29","doi-asserted-by":"publisher","first-page":"5426","DOI":"10.1158\/1078-0432.CCR-07-0674","volume":"13","author":"RJ Brentjens","year":"2007","unstructured":"Brentjens RJ, Santos E, Nikhamin Y, Yeh R, Matsushita M, La Perle K et al. Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin Cancer Res 2007; 13 (Pt 1): 5426\u20135435.","journal-title":"Clin Cancer Res"},{"key":"BFgt2014104_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/jgm.1543","volume":"13","author":"H Yagi","year":"2011","unstructured":"Yagi H, Ogura T, Mizukami H, Urabe M, Hamada H, Yoshikawa H et al. Complete restoration of phenylalanine oxidation in phenylketonuria mouse by a self-complementary adeno-associated virus vector. J Gene Med 2011; 13: 114\u2013122.","journal-title":"J Gene Med"},{"key":"BFgt2014104_CR31","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/74455","volume":"18","author":"JB Latouche","year":"2000","unstructured":"Latouche JB, Sadelain M . Induction of human cytotoxic T lymphocytes by artificial antigen-presenting cells. Nat Biotechnol 2000; 18: 405\u2013409.","journal-title":"Nat Biotechnol"},{"key":"BFgt2014104_CR32","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.bbrc.2006.05.007","volume":"345","author":"T Tsukahara","year":"2006","unstructured":"Tsukahara T, Agawa H, Matsumoto S, Matsuda M, Ueno S, Yamashita Y et al. Murine leukemia virus vector integration favors promoter regions and regional hot spots in a human T-cell line. Biochem Biophys Res Commun 2006; 345: 1099\u20131107.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgt2014104_CR33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1128\/CDLI.8.6.1131-1135.2001","volume":"8","author":"S Neri","year":"2001","unstructured":"Neri S, Mariani E, Meneghetti A, Cattini L, Facchini A . Calcein-acetyoxymethyl cytotoxicity assay: standardization of a method allowing additional analyses on recovered effector cells and supernatants. Clin Diagn Lab Immunol 2001; 8: 1131\u20131135.","journal-title":"Clin Diagn Lab Immunol"},{"key":"BFgt2014104_CR34","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.4049\/jimmunol.130.6.2942","volume":"130","author":"M Kannagi","year":"1983","unstructured":"Kannagi M, Sugamura K, Sato H, Okochi K, Uchino H, Hinuma Y . Establishment of human cytotoxic T cell lines specific for human adult T cell leukemia virus-bearing cells. J Immunol 1983; 130: 2942\u20132946.","journal-title":"J Immunol"},{"key":"BFgt2014104_CR35","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1182\/blood.V87.3.956.bloodjournal873956","volume":"87","author":"K Ohbo","year":"1996","unstructured":"Ohbo K, Suda T, Hashiyama M, Mantani A, Ikebe M, Miyakawa K et al. Modulation of hematopoiesis in mice with a truncated mutant of the interleukin-2 receptor gamma chain. Blood 1996; 87: 956\u2013967.","journal-title":"Blood"},{"key":"BFgt2014104_CR36","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1084\/jem.189.12.1981","volume":"189","author":"T Ohteki","year":"1999","unstructured":"Ohteki T, Fukao T, Suzue K, Maki C, Ito M, Nakamura M et al. Interleukin 12-dependent interferon gamma production by CD8alpha+ lymphoid dendritic cells. J Exp Med 1999; 189: 1981\u20131986.","journal-title":"J Exp Med"},{"key":"BFgt2014104_CR37","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/0092-8674(92)90029-C","volume":"68","author":"Y Shinkai","year":"1992","unstructured":"Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell 1992; 68: 855\u2013867.","journal-title":"Cell"},{"key":"BFgt2014104_CR38","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1172\/JCI66204","volume":"123","author":"C Wang","year":"2013","unstructured":"Wang C, Yi T, Qin L, Maldonado RA, von Andrian UH, Kulkarni S et al. Rapamycin-treated human endothelial cells preferentially activate allogeneic regulatory T cells. J Clin Invest 2013; 123: 1677\u20131693.","journal-title":"J Clin Invest"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2014104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2014104","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2014104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T09:04:09Z","timestamp":1690707849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2014104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,27]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["BFgt2014104"],"URL":"https:\/\/doi.org\/10.1038\/gt.2014.104","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,27]]},"assertion":[{"value":"31 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}